Brendan O'Grady

Overview

Brendan O'Grady received an average of $4M in total compensation, including $727K in salary, at Teva Pharmaceutical Industries between 2019 and 2020.

Source: SEC filings on April 21, 2021 and April 22, 2020.

Related executives

We found 14 more executives who work or worked at Teva Pharmaceutical Industries.

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

Sven Dethlefs

Teva Pharmaceutical Industries

Executive Vice President, North America Commercial

Eric Drap

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

Mark Sabag

Teva Pharmaceutical Industries

Executive Vice President, International Markets Commercial

Eli Kalif

Teva Pharmaceutical Industries

Chief Financial Officer

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

Carlo de Notaristefani

Teva Pharmaceutical Industries

Former Executive Vice President, Global Operations

Michael McClellan

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like